Drug Target Review2024-12-31T08:00:39
MIT's new open-source AI model, Boltz-1, could transform drug discovery by accurately predicting protein structures, offering global access to researchers.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-04T16:00:00Z
Sponsored by Cell Signaling Technology and Myllia
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2026-06-30T14:00:00
Sponsored by Analytik Jena GmbH + Co. KG
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud